NG

Nagaraj Govindappa

BI Biocon: 2 patents #2 of 37Top 6%
Overall (2021): #127,790 of 548,734Top 25%
2
Patents 2021

Issued Patents 2021

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
11060097 Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins Sreesha Srinivasa, USHA BUGHANI, Reshmi NAIR 2021-07-13
11028399 CTLA4/PD1 targeted/immunomodulatory fusion proteins Kedarnath Sastry, Maria Melina Soares 2021-06-08